cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex. The EMBO Journal, 16: 5289-5298. doi: 10.1093/emboj/16.17.5289 DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex The EMBO Journal Vol.16 No.17 pp.5289-5298, 1997 DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex (Draper et al., 1994) (Draper et al., 1994(Draper et al., , 1995 CCR4 complex. DBF2 was identified as a temperature-DBF2 is required for cell cycle progression at the sensitive mutation that causes cell cycle arrest at the end telophase to G 1 cell cycle transition. DBF2 co-immunoof mitosis in which the cells have a fully extended spindle precipitated with CCR4 and CAF1/POP2, a CCR4-and divided chromatin, a characterisitic of telophase associated factor, and co-purified with the CCR4 (Johnston et al., 1990). Consistent with a mitotic role for complex. Moreover, a dbf2 disruption resulted in DBF2, the gene is expressed under cell cycle control in phenotypes and transcriptional defects similar to those M phase. DBF2 encodes a protein kinase and this activity observed in strains deficient for CCR4 or CAF1. ccr4 is also cell cycle regulated, with a peak in late mitosis (Toyn and caf1 mutations, on the other hand, were found to and Johnston, 1994). Despite there being temperatureaffect cell cycle progression in a manner similar to sensitive alleles of DBF2, deletions of the gene are viable that observed for dbf2 defects. These data indicate that (Toyn et al., 1997) due to the existence of a homolog, DBF2 is involved in the control of gene expression and DBF20 (Toyn et al., 1991) . However, deletion of both suggest that the CCR4 complex regulates transcription DBF2 and DBF20 results in strains that are non-viable, during the late mitotic part of the cell cycle.
Introduction
tion. We find that a defect in DBF2 results in phenotypes and transcriptional defects similar to those observed for a The CCR4 protein from Saccharoymces cerevisiae affects ccr4 or caf1 disruption. Conversely, ccr4 and caf1 disrupthe expression of a number of genes and processes. CCR4 tions affect cell cycle progression in late mitosis similarly is required for full derepression of ADH2 and other nonto dbf2 mutations. The CCR4 complex appears, therefore, fermentative genes under glucose-derepressed conditions to be important to the control of specific sets of genes, (Denis, 1984; Denis and Malvar, 1990) . ccr4 mutations including those involved in the late mitotic phase of the also reduce the enhanced gene expression resulting from cell cycle. defects in the SPT6 or SPT10 proteins (Denis, 1984; Denis and Malvar, 1990 ) that appear important in maintaining a proper chromatin structure (Natsoulis et al., 1991; Dollard Results et al., 1994; Bortvin and Winston, 1996) . CCR4 functions downstream of SPT6 and SPT10, at a post-chromatin
DBF2 associates with CCR4 and CAF1
To identify further members of the CCR4 and CAF1 remodeling event (Denis et al., 1994; M.Caserta, personal communication) . In addition to affecting these processes, complex, a yeast two-hybrid screen was carried out using the LexA-CCR4 fusion protein as the bait (Draper et al., a ccr4 allele affects the expression of genes involved in cell wall integrity (A.Sakai, personal communication), in 1995) . The interaction library contained the Escherichia coli-derived B42 activator fused to yeast genomic DNA UV sensitivity (Schild, 1995) and in methionine biosynthesis (McKenzie et al., 1993) . Moreover, CCR4 is fragments under the control of a GAL1 promoter (Zervos et al., 1993) . Fifty six colonies that displayed galactoserequired by different transactivators to function maximally Plasmids that directed the synthesis of LexA fusion proteins were introduced into strain EGY188 containing the LexA-lacZ reporter p34 that contains eight LexA-binding sites upstream of LacZ (Cook et al., 1994) . β-Galactosidase activities represent averages of at least three separate transformants. Standard error of measurements (SEMs) was Ͻ20% in each case. Strains were grown on minimal medium lacking uracil, histidine and tryptophan and supplemented with 2% raffinose and 2% galactose as previously described (Draper et al., 1995) . B42-DBF2 (K195T) is the same as B42-DBF2 (1-561) except for a Fig. 1 . Co-immunoprecipation of B42-DBF2 with CCR4 and CAF1. threonine substitution at residue 195.
(A) Extracts from strain EGY188 containing either B42-DBF2 or B42-SIP1 were incubated with either anti-CCR4 or anti-LexA antibodies and the resulting immunoprecipitates were subjected to dependent activation of both the LexA op -LEU2 and the electrophoresis on a 10% SDS-PAGE gel. CCR4-and HA1-containing
LexA op -lacZ reporters were isolated from~2ϫ10 6 transproteins were detected by Western analysis as described (Draper et al., formants. Library plasmids were isolated from the 56 1995). Lanes 1 and 2, crude extracts containing B42-SIP1 and B42-DBF2, respectively; lane 3, B42-SIP1-containing extracts treated colonies, and each was found to contain one of seven previously to interact with LexA-CCR4 and to be physicand analyzed as described in (A) above. Lane 1, crude extract from EGY188-1 (ccr4); lane 2, crude extract from EGY188-c1 (caf1); lane ally associated with CCR4 in vivo (Draper et al., 1995) .
3, crude extract from EGY188 (wt); lanes 4 and 5, CCR4
The second gene, designated CAF2, was found to be immunoprecipitations using strains EGY188-1 and EGY188, identical to the yeast gene, DBF2. DBF2 is a cell cyclerespectively; lanes 6 and 7, CAF1 immunoprecipitations using strains regulated protein kinase that plays an important role in EGY188-c1 and EGY188, respectively. Lanes 1-3 were developed the telophase to G 1 transition (Toyn and Johnston, 1994) .
with anti-HA1 antibody whereas lanes 4-7 were developed with both anti-CCR4 and anti-HA1 antibodies. For clarity, lanes 4-7 were not
As summarized in Table I, the B42-DBF2 fusion   treated with anti-CAF1 antibody since other experiments have shown containing DBF2 residues 205 to its C-terminus interacted that CCR4 and CAF1 always co-immunoprecipitate (Draper et al., with LexA-CCR4 but failed to interact with the LexA 1995; data not shown).
moiety alone. DBF2 (205-561) is truncated midway in its protein kinase domain and would be expected to be inactive as a protein kinase. To confirm the interaction (data not shown). Other factors, therefore, appear to mediate or stabilize the association of these three proteins. between CCR4 and DBF2, we constructed a full-length DBF2 fused to B42 and expressed it along with LexA-CCR4. The B42-DBF2 (full-length) fusion, which is DBF2 is physically associated with the CCR4 complex capable of complementing phenotypes associated with a dbf2 disruption (data not shown), also interacted with
The physical association of B42-DBF2 with CCR4 was examined by co-immunoprecipitation. Whole-cell extract LexA-CCR4 and did so to the same extent as the truncated B42-DBF2 fusion (Table I) . A LexA-CCR4 derivative expressing the B42-DBF2 (full-length) fusion protein containing an HA1 tag was incubated with CCR4 antibody. containing a deletion in the LRR region (Draper et al., 1994) failed to interact with DBF2 (Table I), suggesting The immunoprecipitated samples were analyzed by Western blotting using antibody directed against CCR4 that the interaction observed between CCR4 and DBF2 was dependent on the presence of the LRR region in the or HA1 (Figure 1 ). The B42-DBF2 protein was coimmunoprecipitated specifically with the CCR4 antibody CCR4 protein.
We also analyzed the ability of B42-DBF2 to interact ( Figure 1A , lane 4) but was not immunoprecipitated by an antibody raised against the LexA protein (lane 5). In with LexA-CAF1. The full-length B42-DBF2 fusion displayed an interaction with either LexA-CAF1 (residues addition, B42-DBF2 was found not to be immunoprecipitated from extracts prepared from a strain lacking CCR4 124-441) (Table I) or with LexA-CAF1 (full-length) (data not shown). In contrast, truncated protein ( Figure 1B , compare lanes 4 and 5). In a control experiment, a B42-SIP1 fusion protein [SIP1 is a protein did not interact with either LexA-CAF1 construct (Table I; data not shown). Also, the interactions between CCR4 associated with the SNF1 protein kinase (Yang et al., 1992) and has been shown not to be associated with the and DBF2, CCR4 and CAF1, and CAF1 and DBF2 essentially were unaffected by deletion of the gene encod-CCR4 complex, data not shown] did not co-immunoprecipitate with CCR4 ( Figure 1A , lane 3). These data indicate ing the other factor, CAF1, DBF2 and CCR4, respectively that B42-DBF2 interacts with CCR4 specifically via the DBF2 moiety. We also showed that B42-DBF2 was also co-immunoprecipitated with CAF1 using an anti-CAF1 antibody ( Figure 1B , lane 7) and was not immunoprecipitated from extracts prepared from a strain lacking CAF1 protein (lane 6). We were not able, however, to coimmunoprecipitate CCR4 or CAF1 with B42-DBF2 in strains deleted for caf1 or ccr4, respectively.
We further examined the physical interaction between DBF2 and CCR4 using a second approach. We have found that CCR4 and a CAF1-6His-tagged protein co-purify following two chromatographic stages: Ni 2ϩ -NTA agarose and Mono-Q chromatography (Figure 2A ). The CAF1-6His gene, containing one copy of a CAF1 gene fused at its 3Ј end to a six histidine tag and integrated into the yeast genome at the TRP1 locus, was able to complement phenotypes associated with a caf1 null allele (data not shown). We subsequently used a LexA-DBF2 construct that was capable of complementing a dbf2 null allele (data not shown) to analyze the co-purification of DBF2 with CAF1. Whole-cell extract prepared from a strain expressing both LexA-DBF2 and CAF1-6His was first passed over an Ni 2ϩ -NTA-agarose column and the bound proteins were eluted with imidazole. The resulting eluant was then passed over an FPLC Mono-Q column, and the bound proteins were eluted with a linear salt gradient. The resulting Mono-Q fractions were subjected to Western blot analyses ( Figure 2B ). The LexA-DBF2 fusion protein co-purified with CAF1 through the Ni 2ϩ -NTA and Mono-Q columns ( Figure 2B ). In a control experiment, LexA alone was not retained on the Ni 2ϩ -agarose column ( Figure 2C , lane 3, LexA, compared with lane 4, LexA-DBF2), indicating that it is the DBF2 moiety of LexA-DBF2 which is co-purifying with CAF1-6His. The co-purification experiment together with the co-immunoprecipitation 4) grown under galactose growth conditions were first treated with antibody and then the immunoprecipitates were analyzed for H1 histone protein kinase activity, as described, following SDS-PAGE and fluorography (Toyn and Johnston, 1994) . The presence of added H1 histone is indicated above the autoradiograms. Lane 1, immunoprecipitation was conducted with HA1 epitope antibody; lanes 2 and 3, immunoprecipitations were conducted with anti-CCR4 antibody; lane 4, same as lane 3 except LexA antibody. (B) Protein kinase assays were conducted as described in (A) except that strain MLF6 containing B42-DBF2 was grown under glucose or galactose growth conditions as indicated. Immunoprecipitations as indicated were conducted as described in (A). (C) Extracts from strain MFL6 containing B42-DBF2 (lanes 2 and 4) or B42 (lanes 1 and 3) grown under galactose growth conditions were assayed for kinase activity as described in (A) above. Lanes 1 and 2, immunoprecipitations were conducted with anti-CCR4 antibody; lanes 3 and 4, immunoprecipitations were conducted with HA1 epitope antibody. (D) Re-immunoprecipitation of extracts following the first immunoprecipitation protein kinase assay was conducted as described in Materials and methods. Lane 1, the first immunoprecipitation was conducted with anti-CCR4 antibody and the second with CCR4 antibody; lane 2, same as lane 1 except that the second immunoprecipitation was conducted with CAF1 antibody; lane 3, same as lane 1 except the second immunoprecipitation was conducted with HA1 antibody; lane 4, same as lane 3 except HA1 antibody was used for both immunoprecipitations.
immunoprecipitates (lane 3), protein kinase activity was treated with HA1 antibody (lane 3). Phosphorylation of CCR4 or CAF1 was not observed from the CCR4/CCR4 much less than observed for the CCR4 immunoprecipitates ( Figure 3B , lane 4). This background level of protein and CCR4/CAF1 double immunoprecipitates (lanes 1 and 2, respectively). Separate experiments showed that CCR4 kinase activity was also observed in anti-CCR4 antibody immunoprecipitates of extracts from a ccr4-deleted strain or CAF1 could be detected by Western analysis from these re-immunoprecipitated extracts (data not shown). (data not shown). Moreover, under galactose growth conditions, increased protein kinase activity was observed These data suggest that neither CCR4 nor CAF1 is an in vitro target for DBF2. for B42-DBF2-containing strains in both the CCR4 ( Figure 3C , lane 2) and HA1 (lane 4) immunoprecipitates
The initial two-hybrid interaction between CCR4 and DBF2 indicated that the DBF2 kinase domain was not as compared with comparable immunoprecipitates obtained from B42-only expressing strains (see lanes 1 and required for interaction with CCR4, although it was required for interaction with CAF1 (Table I) . To determine 3, respectively). These results indicate that the increased protein kinase activity observed under galactose conditions specifically if DBF2 kinase function was required for its interaction with CCR4 or CAF1, a DBF2 allele containing from CCR4 immunoprecipitates was indeed due to the expression of the B42-DBF2 fusion protein.
a mutation (K195T) in the conserved lysine residue of the ATP-binding site catalytic domain of DBF2 subsequently To test if any of the known components in the CCR4 immunoprecipitates can be phosphorylated by DBF2, was analyzed (Toyn and Johnston, 1993) . This dbf2-K195T allele does not complement the dbf2 null allele, is lethal we re-immunoprecipitated CCR4, CAF1 or B42-DBF2 following the kinase assay. First, the CCR4 complex was in the absence of the wild-type DBF2 gene and lacks kinase activity (Toyn and Johnston, 1994) . B42-DBF2-immunoprecipitated with the CCR4 antibody and the B42-DBF2 fusion protein was immunoprecipitated with the K195T interacted with both CCR4 and CAF1 to nearly the same extent as did the wild-type B42-DBF2 protein HA1 antibody. The resulting immunoprecipitates were then subjected to the in vitro kinase assay. CCR4, CAF1 (Table I) . These experiments indicate that DBF2 protein kinase activity is not important for DBF2 association with and B42-DBF2 subsequently were re-immunoprecipitated out of the CCR4 immunoprecipitates by adding, respect-CCR4 or CAF1, and that CCR4 and CAF1 are not in vitro substrates for DBF2 under the conditions utilized. ively, the CCR4, CAF1 and HA1 antibodies, and B42-DBF2 was re-immunoprecipitated from the HA1 immunoprecipitates by adding HA1 antibody again. The resulting A dbf2 disruption causes transcriptional defects similar to those observed with disruption of ccr4 immunoprecipitates were subjected to SDS-PAGE and fluorography ( Figure 3D ). Phosphorylated B42-DBF2 was and caf1 Disruption of CCR4 or CAF1 results in a number of identified in the HA1 double immunoprecipitation (lane 4) and from the CCR4 immunoprecipitate that was retranscriptional phenotypes. We investigated the putative role of DBF2 in several of these transcriptional processes. other processes (Posas et al., 1993; Costigan et al., 1994) (Table III) . These effects are similar to those observed ccr4 mutations were identified originally as specific suppressors of the enhanced ADH2 expression under glucose with defects in the protein kinase C and MAP kinase pathway (Lee et al., 1993; Costigan et al., 1994 ) and growth conditions caused by an spt10 defect (Denis, 1984; see Table II) . Only ccr4 and caf1 alleles display this appear to result from defects in expression of genes involved in cell wall integrity (Roemer et al., 1994; phenotype (Draper et al., 1995) . A dbf2 disruption, which grows almost as well as the wild-type, similarly suppressed Shimizu et al., 1994) . A dbf2 disruption resulted in similar increased sensitivity to caffeine and staurosporine (Table the enhanced ADH II enzyme levels caused by an spt10 defect (Table II) . The dbf2 effect was specific to sup-III). The staurosporine sensitivity and temperature sensitivity of dbf2, caf1 and ccr4 deletions were reversed by pressing spt10-enhanced ADH2 expression, since dbf2 was incapable of suppressing an ADR1-5 c allele which 1 M sorbitol as were the cold sensitivity and temperature sensitivity phenotypes of these disrupted alleles (Table  displays high ADH II enzyme levels under repressed conditions similar to those observed in an spt10-containing III) (A.Sakai, personal communication). We also observed that ccr4-(B.Anderson, personal communication), caf1-strain. In contrast, a deletion of DBF20, a non-cell cyclecontrolled homolog of DBF2, had no effect on spt10-and dbf2-containing strains were hypersensitive to elevated levels of the Li ϩ ion (Table III) . It should be noted that enhanced ADH2 expression (Table II) .
ccr4 and caf1 mutations also cause a defect in noncombining the dbf2 disruption with either a ccr4 or caf1 disruption resulted in no increased sensitivity of any of fermentative growth at 37°C, a phenotype we observed to be shared by dbf2 (Table III , see glycerol column). This the above phenotypes, suggesting that DBF2 functions in the same pathway as CCR4 and CAF1. arrest of growth on glycerol by dbf2 was not a mitotic arrest as is observed with temperature-sensitive alleles of
In addition, we examined the role of DBF2 in affecting LexA transactivator function. Both ccr4 and caf1 defects DBF2 (data not shown). While a ccr4 disruption affects the non-fermentative expression of ADH2 by 5-fold (Denis reduce the ability of several different LexA activators to activate a LexA-lacZ reporter~2-to 3-fold (Draper et al., and Malvar, 1990 ) and caf1 by~2-fold (Draper et al., 1995) , a dbf2 effect on ADH2 expression under non-1994, 1995) . A dbf2 disruption affected the function of LexA-B42, LexA-ADR1-TADIV and LexA-CCR4-1-fermentative growth conditions was not observed (data not shown). caf1 and ccr4 defects also cause increased 345 by~2-to 3-fold, although it had little or less effect on LexA-CAF1 or LexA-ADR1-full length activation sensitivity to staurosporine, a protein kinase inhibitor (A.Sakai, personal communicaation) and to caffeine, two (data not shown). These results are similar to those observed for caf1 and ccr4 defects, but the effects are not compounds linked to effects on cell wall integrity and as general as for the defects in the CAF1 and CCR4 genes.
The above results indicate that DBF2 is required for processes similar to those that require CCR4 and CAF1. firstly, they displayed an increased proportion of late 
Growth phenotypes were determined on YEP plates containing 2% glucose as the carbon source except as indicated. Stauro. plates contained 2 mM staurosporine; sorb. plates contained 1 M sorbitol; Gly ϭ YEP plates containing 3% glycerol; caffeine plates were supplemented with 8 mM caffeine; LiCl plates were supplemented with 0.3 M LiCl. The designation 'ϩ' refers to good growth, 'w' to minimal growth, and '-' to no growth. Growth in strain S7-4A was compared with its isogenic wild-type parent S7-4A-cmyc which behaved similarly to strain EGY188. Log phase cultures were grown in YEP medium plus glucose at 30°C and stained with DAPI. Two hundred cells of each culture (as indicated) were observed by fluorescence microscopy. Cells with divided chromatin had elongated spindles similar to those observed with dbf2-containing strains (Toyn and Johnston, 1994) . a wt, strain 612-1d; b ccr4, strain 612-1d-2A; c wt, strain 935-2; d caf1, strain 935-2-3. CLB2, prevents B cyclin kinase deactivation, causing a stage-specific arrest of the cell cycle in telophase (Surana et al., 1993) . Furthermore, yeast mutants that are partially defective for B cyclin kinase deactivation, as a result of mutations in the relevant regulatory genes, are hypersensitive to overexpression of CLB2 (Shirayama et al., 1994; Toyn et al., 1997) . To test for involvement in B cyclin kinase deactivation, the GAL7-CLB2 overexpression and caf1 strains were unable to grow on galactose medium except caf1 is strain 935-2-3 and CAF1 is strain 935-2.
when the GAL7-CLB2 gene was expressed, whereas isogenic control strains were not affected. These results confirmed that both CCR4 and CAF1 proteins contribute to the deactivation of the B cyclin kinase in vivo. Thus, mitotic cells in log phase cultures, and, secondly, they were hypersensitive to CLB2 overexpression. the three presently identified components of the CCR4 transcription complex, i.e. CCR4, CAF1 and DBF2, all Log phase ccr4, caf1 and isogenic control cultures were stained with 4Ј,6Ј-diamidino-2-phenylindole (DAPI), and affect mitotic exit. It therefore seems likely that some of the target genes regulated by this transcription complex the percentage of cells with buds and with divided chromatin was counted, as an indicator of the number of are involved in the regulation of mitotic exit.
Other phenotypes typically observed with a dbf2 disruptelophase cells (Table IV) . Both mutants showed an increase in the budded population, consistent with a mitotic tion were not observed, however, with ccr4 or caf1 defects. A dbf2 disruption is synthetically lethal in combination delay, but, more importantly, the ccr4 and caf1 cultures had~3-fold and 2-fold increases in the percentage of total with dbf20 (Toyn et al., 1991) , sic1 (Donovan et al., 1994) or swi5 (Toyn et al., 1997) . Neither ccr4 nor caf1 were cells with divided chromatin, respectively. This suggests that the ccr4 and caf1 genotypes result in a delayed exit synthetically lethal with these mutated alleles (data now shown). Moreover, while DBF2 expression is cell cyclefrom mitosis, at least in terms of causing some of the cells to spend more time in telophase. regulated, reaching a maximum at the anaphase to telophase transition ( Figure 5 ; Johnston et al., 1990 ; Toyn Deactivation of the B cyclin kinase activity is necessary for the exit from mitosis, and it has been shown that and Johnston, 1994), neither CCR4 nor CAF1 gene expression was found to be under cell cycle control ( Figure 5 ). overexpression of CLB2, or expression of non-degradable Discussion spindles, and because a caf1 or ccr4 disruption in combination with excess CLB2 protein resulted in a late mitotic
DBF2 is a component of the CCR4 complex
block, it is clear that CCR4 and CAF1, in conjunction DBF2, a cell cycle-regulated protein kinase, was identified with DBF2, are important factors for progression by the two-hybrid assay as interacting with the general through mitosis. transcriptional regulator CCR4. The physical in vivo However, the CCR4 complex does not function solely interaction of DBF2 with CCR4 was confirmed by coto bind DBF2, since the phenotypes resulting from defects immunoprecipitation studies. CAF1, which is tightly in these respective factors were overlapping but not associated with CCR4, also interacted in the two-hybrid identical. A dbf2 disruption was synthetically lethal in assay with DBF2 and co-immunoprecipitated with it. In combination with swi5 (Toyn et al., 1996) , dbf20 (Toyn addition, we demonstrated that DBF2 co-purified with et al., 1991) or sic1 (Donovan et al., 1994) whereas a ccr4 CAF1 and CCR4 following two chromatographic steps, disruption did not display these phenotypes. Moreover, the indicating that all three proteins are together in one cell cycle regulation of DBF2, CCR4 and CAF1 gene complex. Whether CCR4 or CAF1 bind directly to DBF2 expression was distinct. While defects in these genes is not known. The CCR4 complex contains additional affected cell cycle progression, the ccr4 and caf1 phenoproteins besides CAF1 and DBF2 (Draper et al., 1994) types were less severe. This suggests that the essential and it may be that these proteins stabilize the complex DBF2 function in late mitosis is not shared by CCR4 and between CCR4, CAF1 and DBF2. In support of this idea, CAF1, although other functions in late mitosis are shared. the dual two-hybrid interactions between CCR4, CAF1 Conceivably, DBF2 may have an adventitious role in the and DBF2 were not affected by the absence of the third CCR4 transcription complex; that is to say it functions factor, consistent with a large complex stabilized by principally in pathways controlling the end of mitosis and multiple interactions between many proteins. secondarily in transcriptional events, and that these latter The physical association of DBF2 with CAF1 and events are not essential for the telophase-G 1 transition. CCR4 does not imply, however, that all of the DBF2 in Alternatively, as mentioned above, not all of the DBF2 in the cell is found in the CCR4 transcriptional regulatory the cell may be complexed with CCR4 and CAF1, which complex. The co-purification of LexA-DBF2 with CCR4
would result in some DBF2 having partial and separate and CAF1-6His indicated that not all of the LexA-DBF2 functions in the cell. In addition, the CCR4 complex may was present in the CCR4 complex (Figure 2 ). While this have multiple roles and contacts. For example, inactivating can be interpreted to mean that a significant amount of CCR4 in this complex would affect a subset of interactions DBF2 is not with CCR4, LexA-DBF2 was overexpressed and processes resulting in phenotypes that may be only relative to the amount of DBF2 in the cell and was partially similar to inactivating DBF2 or any other comexpressed in a non-cell cycle-controlled manner. DBF2 ponent of the complex. Such multi-faceted roles for has also been shown to act at least at two different points different components of protein complexes are often in the cell cycle (Johnston et al., 1990; Donovan et al., observed as, for example, in the yeast transcriptional 1994), and it is possible that it associates with different holoenzyme (Hengartner et al., 1995) . proteins at different stages in the cell cycle.
DBF2 affects transcription
While dbf2 mutations were identified originally as causing DBF2 links the function of the CCR4 complex to cell cycle regulation a block in cell cycle progression, a dbf2 deletion was viable and resulted in transcriptional phenotypes similar Mutations in DBF2 result in a dumb-bell shape cell morphology, with cells characterized by divided chromatin to those observed for ccr4 or caf1 disruptions. A dbf2 disruption was (i) staurosporine and caffeine sensitive, the and fully extended spindles indicative of a block in late mitosis. The expression of the DBF2 gene, the former of which was suppressible by sorbitol, indicative of an effect on cell wall integrity genes; (ii) resulted in a phosphorylation state of the protein and DBF2 protein kinase activity are all under cell cycle control. The 37°C glycerol defect; (iii) suppressed spt10-enhanced ADH2 expression; and (iv) decreased the ability of some conversion of DBF2 from the phosphorylated to the nonphosphorylated form coincides with the point of action of but not all LexA transactivators to function. dbf2 has also been found to affect the expression of several lacZ reporter DBF2 at the end of mitosis, suggesting that the nonphosphorylated DBF2 contains the protein kinase activity.
plasmids (unpublished observations). These effects suggest that DBF2 functions as a transcriptional regulator. Our observation that CCR4 immunoprecipitates were able to phosphorylate histone H1 in vitro indicates that this One model describing DBF2 control of cell cycle events would be that DBF2 phosphorylates factors which allow CCR4 complex contains a protein kinase. The fact that this kinase activity increased when the B42-DBF2 protein specific cell cycle genes to be transcribed during late mitosis. DBF2 and the CCR4 complex might represent, was present indicates that it is the DBF2 in the complex which is responsible for this kinase activity.
therefore, a signaling processor. Different signals generated, for example, from a shift to non-fermentative growth The physiological substrates of DBF2 remain, however, undefined. Neither CCR4 nor CAF1 were phosphorylated conditions or from progression through the cell cycle would influence the activity and interactions of comin vitro by DBF2, although DBF2 itself became phosphorylated in vitro. In addition, the association of DBF2 ponents of the CCR4 complex and result in bringing about a subset of specific transcriptional events. Since CCR4 with CCR4 and with CAF1 did not require DBF2 kinase activity. Because defects in CCR4 and CAF1 resulted in acts at a post-chromatin remodeling event in its effects on transcription (M.Caserta, personal communication), a cell cycle delay in late mitosis in which increased numbers of cells had divided chromatin and elongated DBF2 would also presumably act at this level. The CCR4 cloning a 2 kb HincII fragment of pRS304-DBF2-cmyc (Toyn and complex might stabilize or recruit the holoenzyme complex Johnston, 1994) into the LexA202-1 vector whose BamHI site had been (Hengartner et al., 1995) Immunoprecipitation and kinase activity assay Yeast strains used in this study are listed in Table V. Yeast generally Yeast strain EGY188 containing the plasmid B42-DBF2 was grown were cultured on YEP medium (1% bactopeptone, 1% yeast extract) overnight on minimal medium lacking tryptophan and containing either containing either 8% glucose or 3% ethanol or on minimal medium 2% each of galactose and raffinose or 2% glucose. Cells were pelleted lacking uracil, histidine and/or tryptophan containing 8% glucose, 2% and the whole cell protein was extracted in lysis buffer (50 mM K each of ethanol and glycerol, or 2% each of raffinose and galactose.
phosphate, pH 7.7, 150 mM KCl, 20% glycerol, 1 mM NaPP i , 1 mM ADH II enzyme assays were conducted as previously described following NaF, 1 mM EDTA, 2 mM MgC1 2 , 1% NP-40 plus protease inhibitors). growth on YEP medium, and β-galactosidase assays were conducted on Then 250 μg of protein was incubated with 2 μg of CCR4 antibody for minimal medium as previously described (Cook et al., 1994) . α-Factor 45 min at 4°C and mixed with 20 μl of protein A-agarose for an arrest was conducted as previously described (Johnston et al., 1990) .
additional 30 min. The beads were pelleted by centrifugation in a microcentrifuge and washed in 3ϫ1 ml of the lysis buffer, 1 ml of lysis Two-hybrid screen buffer with 1 M KC1 and 1 ml of the Triton X-100 wash buffer. SDS A yeast interaction library containing yeast genomic sequences fused to sample buffer (20 μl) was added to the beads and the beads were boiled the B42 activation domain (Zervos et al., 1993) was used to transform for 4 min before being loaded on a 10% SDS-PAGE gel. Western blot (Ito et al., 1983) strain EGY188 containing the LexA(1-87)-CCR4 analysis was carried out as described (Draper et al., 1995) . After the fusion and the LexA op -lacZ reporter 34 that has eight LexA-binding sites immunoprecipitations, in vitro kinase assays using H1 histone were upstream of the GAL1-lacZ reporter (Cook et al., 1994) . Identification of conducted as described by Toyn and Johnston (1994) . Immunoprecipitcolonies and screening for galactose and plasmid dependence were done ations using anti-CCR4 or anti-CAF1 antibody were conducted as as described (Zervos et al., 1993; Draper et al., 1995) . described previously (Draper et al., 1994 (Draper et al., , 1995 , and ECL analysis (Pierce) was conducted according to the manufacturer's instructions. ReConstruction of fusion proteins immunoprecipitation experiments were carried out exactly as described The B42-DBF2 full-length fusion was a gift of S.Komarnitsky and in Vallari et al. (1992) . contained the complete sequence of DBF2 fused to B42 in the pJG4-5 vector (Zervos et al., 1993) . The B42-DBF2-K195T fusion was conChromatographic analysis of the CCR4 complex structed by placing a 2.3 kb SalI fragment of DBF2-K195T at the XhoI
The yeast strain MLF6 (EGY191-2 except trp1::CAF1-6His-TRP1) containing the LexA-DBF2 plasmid was grown overnight on minimal site of the pJG4-5 vector. The LexA-DBF2 fusion was constructed by medium lacking histidine and tryptophan and containing 2% glucose.
domains interspersed with inhibitory domains: evidence for a repressor Cells were pelleted by centrifugation at 3000 r.p.m. at 4°C for 5 min.
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